Jin Medical International (ZJYL) Notes Payables (2023 - 2025)

Jin Medical International has disclosed Notes Payables across 3 years of filings, most recently posting $18.8 million for Q3 2025.

• Notes Payables for Q3 2025 came in at $18.8 million, up 66.37% year-over-year; the trailing twelve-month figure through Sep 2025 was $18.8 million (up 66.37% YoY), and the FY2025 annual result was $18.8 million, up 66.37% from the prior year.
• Notes Payables came in at $18.8 million for Q3 2025 at Jin Medical International, up from $11.3 million in the prior quarter.
• In the past five years, Notes Payables ranged from a high of $18.8 million in Q3 2025 to a low of $4.1 million in Q3 2023.
• The 3-year median for Notes Payables is $11.3 million (2024), against an average of $11.4 million.
• Across the five-year window, Notes Payables surged 175.28% in 2024 and soared 66.37% in 2025, its largest moves.
• Jin Medical International's Notes Payables stood at $4.1 million in 2023, then surged by 175.28% to $11.3 million in 2024, then jumped by 66.37% to $18.8 million in 2025.
• The last three Notes Payables figures came in at $18.8 million (Q3 2025), $11.3 million (Q3 2024), and $4.1 million (Q3 2023), per Business Quant data.